You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radiopharmaceuticals

Showing 26 - 50 of 204
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Beijing (99mTc-MIRC213)

Recruiting
  • Breast Cancer
  • Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Nov 18, 2022

Cardiovascular Diseases Trial in New York (18F-mFBG for intravenous administration)

Recruiting
  • Cardiovascular Diseases
  • 18F-mFBG for intravenous administration
  • New York, New York
    Mount Sinai Morningside
May 23, 2022

Tumors, Tumors Malignant Trial in Heidelberg (18F-LY3546117 Injection, PET Scan)

Recruiting
  • Neoplasms
  • Neoplasms Malignant
  • 18F-LY3546117 Injection
  • PET Scan
  • Heidelberg, Victoria, Australia
    Olivia Newton-John Cancer Institute and Austin Health
Apr 22, 2022

Glioma, Childhood Brainstem, Neuroblastoma Trial in San Francisco, Boston (External beam radiotherapy,

Not yet recruiting
  • Glioma, Childhood Brainstem
  • Neuroblastoma
  • External beam radiotherapy
  • 131I-Metaiodobenzylguanidine (MIBG)
  • San Francisco, California
  • +1 more
Aug 17, 2023

Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)

Recruiting
  • Glioblastoma Multiforme
  • 11C-Methionine PET/CT
  • Brno, Czech Republic, Czechia
    Masaryk Memorial Cancer Institute
Nov 3, 2022

Mitochondria in Cardiomyocytes in Heart Failure

Not yet recruiting
  • Heart Failure
  • Coronary Artery Disease
  • coronary artery bypass grafting
  • (no location specified)
Mar 3, 2023

Liver Cancer Trial in Chang chun (FAPI PET)

Recruiting
  • Liver Cancer
  • FAPI PET
  • Chang chun, Jilin, China
    China-Japan Union Hospital
Mar 28, 2023

Renal Disease Trial in Boston (Imaging Time)

Completed
  • Renal Disease
  • Imaging Time
  • Boston, Massachusetts
    Boston Children's Hospital
Oct 6, 2021

Muscle Weakness, XLH Trial (MRI)

Not yet recruiting
  • Muscle Weakness
  • XLH
  • MRI
  • (no location specified)
Mar 28, 2022

Metastatic Breast Cancer Trial in Dijon (18F Fluoroestradiol Radiopharmaceutical with PET/CT)

Recruiting
  • Metastatic Breast Cancer
  • 18F Fluoroestradiol Radiopharmaceutical with PET/CT
  • Dijon, France
    CGFL
Aug 2, 2022

Neuroendocrine Tumors Trial in Beijing (Gallium-68 NODAGA-LM3 PET/CT, Gallium-68 DOTA-LM3 PET/CT, Gallium-68 DOTATATE PET/CT)

Completed
  • Neuroendocrine Tumors
  • Gallium-68 NODAGA-LM3 PET/CT
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Dec 20, 2021

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

Recruiting
  • Prostate Cancer
  • +5 more
  • 177Lu-rhPSMA-10.1 injection
  • 18F-rhPSMA-7.3 injection
  • Glen Burnie, Maryland
  • +3 more
Feb 2, 2023

FES F18 PET/CT in Metastatic Breast Cancer Patients

Recruiting
  • Metastatic Breast Cancer
  • 18F Fluoroestradiol Radiopharmaceutical with PET/CT
  • Long Beach, California
  • +5 more
Jan 19, 2023

Neuroblastoma Trial in Montréal, Sherbrooke (Radiopharmaceutical 68Ga-DOTATATE)

Recruiting
  • Neuroblastoma
  • Radiopharmaceutical 68Ga-DOTATATE
  • Montréal, Quebec, Canada
  • +2 more
Jan 3, 2023

Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

Recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • +6 more
  • Omaha, Nebraska
    Urology Cancer Center/XCancer
Nov 29, 2022

Cardiovascular Risk Factor, Circadian Dysregulation, Obesity Trial in Portland (radiation, behavioral, drug)

Recruiting
  • Cardiovascular Risk Factor
  • +2 more
  • PET Imaging
  • +4 more
  • Portland, Oregon
    Oregon Health & Science University
Feb 3, 2022

Colorectal Cancer Trial in Beijing (68Ga-EB-ss-CPT, 64Cu-EB-ss-CPT)

Recruiting
  • Colorectal Cancer
  • Beijing, Beijing, China
    Chinese Academy of Medical Science & Peking Union Medical Colleg
Jun 6, 2023

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Cancer Trial (18F-FAPI PET/CT and 18F-FDG PET/CT)

Not yet recruiting
  • Cancer
  • 18F-FAPI PET/CT and 18F-FDG PET/CT
  • (no location specified)
Aug 1, 2022

Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 2, 2023

Testicular Germ Cell Tumor Trial in Saint-Petersburg (Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel

Recruiting
  • Testicular Germ Cell Tumor
  • Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel lymph node using indocyanine green dye with/without methylene blue dye.
  • Radiopharmaceutical administration (Technetium/methylene blue)
  • Saint-Petersburg, Russian Federation
    Federal State Budgetary Institute N.N. Petrov National Medical R
Nov 10, 2023

Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI Trial (drug, procedure, genetic)

Not yet recruiting
  • Breast Cancer Female
  • +4 more
  • (no location specified)
Aug 8, 2023

Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 1, 2022

Pancreatic Cancer, Cholangiocarcinoma Trial in Amsterdam ([68Ga]Ga-FAPI-46 PET/CT)

Recruiting
  • Pancreatic Cancer
  • Cholangiocarcinoma
  • [68Ga]Ga-FAPI-46 PET/CT
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location VUmc
Jul 13, 2023

Glioma Trial in Indianapolis (FET F-18, O-15 Radioisotope, CT scan)

Recruiting
  • Glioma
  • FET F-18
  • +4 more
  • Indianapolis, Indiana
    Indiana University School of Medicine
Sep 7, 2022